The International League Against Epilepsy has revised its epilepsy classification system in an effort to inform epilepsy research and aid drug development.
The large number of recalls of medical devices has pointed to a need for more active monitoring of product performance from the standpoints of both safety and efficacy.
New evidence on diabetic neuropathy has emerged since the ADA's last published a position statement in 2005.
Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.
There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.
Female athletes face a greater incidence of and longer recovery time from concussion compared with males.
Comorbid psychological conditions affect cognitive function in Parkinson's disease, and treatment can be complicated by overlapping symptoms.
The National Academies of Sciences, Engineering, and Medicine have released a report
The new guidelines offer guidance on dosing, including reduced starting and maintenance dosing and safety precautions for diagnosing and treating complications.
Functional MRI may provide a less-invasive option for evaluating memory function in patients undergoing epilepsy surgery.
The review found that there is substantial evidence that supports folic acid supplementation during pregnancy.
Keeping abreast of changing payment models and regulations is key to maximizing your practice's finances.
SPECT imaging can be more accurate in the diagnosis of traumatic brain injury and post-traumatic stress disorder than CT or MRI.
The guidelines were developed by a group of RLS experts from the US and Europe who utilized the American Academy of Neurology's 2004 guideline development manual.
Recovery time varies depending on which class of medication the patient is overusing.
Learn about the key scientific sessions taking place at CNS 2016 and follow along with Neurology Advisor for full meeting coverage.
Acupuncture, neurostimulation, and other alternative treatments have been associated with up to a 50% reduction in headache days.
Neuroimaging and if necessary, genetic testing, can help to confirm an FTD diagnosis.
The 4th World Parkinson Congress takes September 20-23, 2016 in Portland, Oregon.
A proper MS diagnosis can only be made after obtaining imaging from the entire brain and understanding the clinical context.
The new guidelines include a step-by-step diagnostic algorithm for use in the clinical setting, as well as a special emphasis on neurobehavioral impairment.
Neurologists should collaborate with other specialties in order to increase awareness of migraine prevalence in men.
It has been proposed that the gut microbiome may be an important environmental risk factor in MS.
Myoclonic seizures may be easily mistaken for a possible tic disorder if the proper patient monitoring is not conducted during diagnosis.
It's important for pediatric neurologists to spend time preparing the patient for the transition to adult care.
According to a 2010 report based on a survey of caregivers of people with DLB, 78% of cases were initially misdiagnosed.
Medication, plus a relatively sedentary lifestyle, places people with epilepsy at great risk of metabolic syndrome and its various complications.
While supplementation has produced a positive response in disease activity, adverse events based on dosing are concerning.
The guidelines are the result of a consensus of an international task force of MG experts.
One of the biggest hurdles is getting the patient to be honest and open with you about bladder problems.
The registry is a centralized data collection system that analyzes data on quality of care and patient outcomes.
More than 50% of patients with migraine are treated with opioids in the ED despite known risks.
The DMD space is becoming increasingly crowded as the FDA works to identify a drug worth approving.
Some patients who are approaching seizure control can achieve improvement or seizure freedom by addressing sleep issues.
Neurology Advisor reviews the upcoming agenda for the CMSC annual meeting.
Theodore Henderson, MD, PhD, suggests that perhaps it's time to check our bias at the door.
With a lack of official treatment guidelines, clinicians should remember to treat the patient, not just the condition.
Huma U. Sheikh, MD, provides highlights of recent clinical research in headache.
Children and teens with chronic headache pain should be screened for anxiety and depression.
Physical comorbidities are mediated by depression in MS.
Those treated with phenytoin saw a 30% reduction in retinal nerve fiber loss.
Hundreds of neurologists advocate for Congress to support the Telestroke FAST Act and the BRAIN Initiative.
Patients undergoing cardiac surgery should be evaluated for cardiovascular disease to assess stroke risk.
Dr Mary Zupanc of CHOC Children's recounts a challenging case of refractory seizures in a child with a history of arteriovenous malformation and intracranial hemorrhage.
When first-line therapies fail, physicians must consider several factors when choosing the next course of treatment for their RRMS patients.
The diagnosis and management of concussion is still a grey area for sports medicine specialists.
Antibodies in the CSF may be able to seek out and eliminate JC polyomavirus variants.
Research has shown a confounding link between nicotine and reduced risk of Parkinson's disease.
There is much promising research ongoing in the world of migraine prevention and treatment.
New research suggests that fibromyalgia is primarily a peripheral nerve disorder that causes central nervous system sensitization.
Combat veterans face an elevated risk of developing PTSD and comorbid depression, which severely affects quality of life.
Taking proper precautions before, during, and after pregnancy can help promote a safe and healthy experience for both mother and baby.
Exercise and general increases in daily physical activity can help improve balance, reduce fatigue, and regain mental clarity in patients with MS.
The two disorders overlap across several planes, indicating the possibility of a shared pathopysiology.
Our sister site MPR has partnered with ICD-10 Charts to offer a free interactive ICD-9 conversion tool and reference charts that cover the most commonly used codes by therapeutic area.
Parkinson's disease psychosis is underreported and is difficult to treat, but a new drug in late-stage development is a promising therapy.
Over 60% of people with Parkinson's disease will have REM sleep behavior disorder, endangering them and their partners during the night.
With an increasing emphasis on value, health care providers who treat sleep disorders should focus on adopting quality measures to ensure patient-centered care.
A patient presenting with headache may have a broad range of symptoms. Here's how to narrow down your diagnosis.
Could a proposal by an expert panel undermine years of progress made in the identification and intervention of autism?
Addressing neuropathy early on in prediabetes is essential to successful symptom management.
Researchers are nearly convinced narcolepsy is the result of an autoimmune response, but one crucial factor is still missing.
A multi-faceted approach is best when treating pediatric headache.
Neuroimaging could enable better classification of patients and provide information on affected brain regions.
Overlapping clinical characteristics between women with migraine and those using contraceptives may indicate an elevated risk of stroke.
Long-term exposure to hyperglycemia may have ill effects on the brain, making diabetes patients more prone to dementia and cognitive impairment.
Natalia Rost, MD, shares her thoughts on the upcoming agenda for AAN 2015.
Stress is the most common self-reported trigger of seizure in people with epilepsy.
Studies have shown CBT to be as effective as medication and less costly for fibromyalgia treatment.
Determinations of brain death are becoming increasingly clouded by special circumstances, religious beliefs, and inconsistencies across state lines.
Thiamine, a simple supplement that helps reverse Wernicke syndrome, is often underused and misused.
Misconceptions about vaccines and autism persist despite growing scientific evidence that no link exists.
Sleep experts weigh in on whether the NSF's new sleep recommendations are appropriate and beneficial for the general population.
The role of GCH1 mutations in Parkinson's disease is complicated by the mutation's seemingly exclusive role in dopa-responsive dystonia.
Implementing a ketogenic diet in patients with drug-resistant epilepsy could produce significant reductions in seizure frequency.
Advancements in mobile detection technology allow immediate assessment, but can't replace a medical professional's diagnosis.
The most recognized symptom of MS is fatigue, a hard to treat comorbidity that can manifest into other conditions.
The affect of stroke on young adults goes far beyond functional disabilities.
The role of teleneurology can grow far beyond critical stroke care, but only if medical liabilities and insurance steps out of the way.
Vestibular migraine may have finally won its own diagnostic criteria, but the condition is still shrouded in uncertainties.
With no established guidelines, much of the decisions for management of hypertension during stroke are based on clinician experience.
Vitamin D deficiency is known to contribute to neurodegenerative diseases like dementia, however its connection to ALS is not yet well understood.
Closed-loop neurostimulation technology is being investigated for movement disorders, headache, and even some neuropsychiatric disorders.
A personalized approach to treating epileptic seizures ensures a balance of effectiveness and tolerability for each patient.
While new technology is making it more accessible, the clinical applications of genome sequencing are still being explored.
Tech may be at the top of every doctor's wish list, but there's even something here for traditionalists.
Researchers are hoping that anti-amyloid and other treatments can help slow the dementia epidemic.
Motion-sensing technology provides a lot of data, but researchers still aren't sure if it's clinically useful.
The medical community is taking steps to clarify delirium pathology and diagnosis.
Robotics, stem cell therapy, and computer-controlled interfaces are promising, but cost may slow adoption.
Adopting a more open-access environment crucial to developing new technologies for understanding the human brain.
Cerebrospinal fluid, neuroimaging techniques, and blood and skin peripheral tissues may hold the answers to recognizing Alzheimer's disease earlier.
Advanced imaging technologies to monitor multiple sclerosis (MS) are being developed but have been plagued by high costs and invasive procedures.
The broad pathology of sleep disorders can make diagnosis and treatment complicated.
Diagnosis of rapidly progressive dementias is difficult due to broad pathology and underdeveloped diagnostic criteria for clinical settings.
Several anti-diabetes agents hold promise for Parkinson's disease-related neurodegeneration.
If the UTHealth mobile stroke unit program can show that treating ischemic stroke within 60 minutes is feasible and cost effective, more may start rolling out nationally.
As part of an industry effort to reduce wasteful practices that contribute to healthcare costs, the American Academy of Neurology published its recommendations, code-named "Choose Wisely."
Young people might not understand the health consequences of participating in stunts that help them feel like part of the crowd.
The revision to the diagnostic manual does away with the complex multiaxial organization in favor of a simpler chapter order of disorders.
Neurology Advisor Articles
- New Sleep Apnea Clinical Practice Guidelines
- International League Against Epilepsy Updates Epilepsy Classification System
- Patent Foramen Ovale Closure Reduces Stroke Risk in Patients With Inherited Thrombophilias
- In Refractory Status Epilepticus, Lacosamide May Be a Good Option
- The Handoff: Your Week in Neurology News - 3/23/17